Evidence map›Paper›PMID 30021941›Full record

ArticleInternational journal of molecular sciences2018

Protective Effects of 6-(Methylsulfinyl)hexyl Isothiocyanate on Aβ

Fabiana Morroni, Giulia Sita, Agnese Graziosi, Eleonora Turrini, Carmela Fimognari, Andrea Tarozzi, Patrizia Hrelia

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Glucosinolate Derivatives: Emerging Anti-Inflammatory Agents.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Therapeutic Candidates for Alzheimer's Disease: Saponins.International journal of molecular sciences · 2023
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Frontiers in pharmacology · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Nrf2 Suppresses Oxidative Stress and Inflammation inMolecular and cellular biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fabiana MorroniDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, via Irnerio 48, 40126 Bologna, Italy. fabiana.morroni@unibo.it.ORCID 0000-0001-6494-5968
Giulia SitaDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, via Irnerio 48, 40126 Bologna, Italy. giulia.sita2@unibo.it.ORCID 0000-0001-6627-7078
Agnese GraziosiDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, via Irnerio 48, 40126 Bologna, Italy. agnese.graziosi2@unibo.it.ORCID 0000-0002-4992-7902
Eleonora TurriniDepartment for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Corso d'Augusto, 237, 47900 Rimini, Italy. eleonora.turrini@unibo.it.ORCID 0000-0003-4743-1126
Carmela FimognariDepartment for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Corso d'Augusto, 237, 47900 Rimini, Italy. carmela.fimognari@unibo.it.ORCID 0000-0002-2461-8214
Andrea TarozziDepartment for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Corso d'Augusto, 237, 47900 Rimini, Italy. andrea.tarozzi@unibo.it.
Patrizia HreliaDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, via Irnerio 48, 40126 Bologna, Italy. patrizia.hrelia@unibo.it.ORCID 0000-0002-8415-3711
University of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is the most common form of dementia among older people. Although soluble amyloid species are recognized triggers of the disease, no therapeutic approach is able to stop it. 6-(Methylsulfinyl)hexyl isothiocyanate (6-MSITC) is a major bioactive compound in Wasabia japonica, which is a typical Japanese pungent spice. Recently, in vivo and in vitro studies demonstrated that 6-MSITC has several biological properties. The aim of the present study was to investigate the neuroprotective activity of 6-MSITC in a murine AD model, induced by intracerebroventricular injection of β-amyloid oligomers (Aβ

Indexed as

ApoptosisOxidative StressAmyloid beta-PeptidesAnimalsCaspasesCell DeathCognition DisordersExtracellular Signal-Regulated MAP KinasesGlycogen Synthase Kinase 3 betaHippocampusInflammationIsothiocyanatesMiceNeuronsNeuroprotective AgentsOxidation-Reduction6-(Methylsulfinyl)hexyl isothiocyanateAmyloid beta-PeptidesCaspasesExtracellular Signal-Regulated MAP KinasesGlycogen Synthase Kinase 3 betaIsothiocyanatesNeuroprotective Agents6-(methylsulfinyl)hexyl isothiocyanateAlzheimer’s diseaseAβ oligomersneuroinflammationneuroprotectionoxidative stress

Identifiers

PMID30021941
PMCPMC6073905
OpenAlexW2883631240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.